Guide development and investment priorities in the field of non-viral vectors and extracellular vesicles.
This involves compiling a summary identifying the current situation (state of the art, technological barriers limiting development, French strengths) and anticipating likely developments (medico-economic, incremental innovations, and disruptive innovation).
